[[missing key: loading-pdf-error]] [[missing key: loading-pdf-link]]
Abstract
Bill & Melinda Gates Foundation, Foundation for Innovative New Diagnostics (FIND), the Special Programme for Research & Training in Tropical Diseases (TDR) at the World Health Organization, and the National Institute of Allergy and Infectious Diseases. Meeting abstracts - A single PDF containing all abstracts in this supplement is available at http://www.biomedcentral.com/content/files/pdf/1753-6561-4-S3-full.pdf.EMPTY In theory, immunodiagnosis should be able to discriminate between latent and acute TB, because the immunopathoogic nature of the disease means there must be significant differences in either the type and/or magnitude of immune response that develop.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer